S
ARKG icon

Syntrinsic’s ARK Genomic Revolution ETF ARKG Stock Holding History

Syntrinsic’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.74K Hold
107
– – ﹤0.01% 71
2024
Q2 		$2.51K Hold
107
– – ﹤0.01% 76
2024
Q1 		$3.08K Hold
107
– – ﹤0.01% 78
2023
Q4 		$3.51K Hold
107
– – ﹤0.01% 83
2023
Q3 		$2.98K Buy
+107
New +$3.5K ﹤0.01% 75

Other funds holding ARKG

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Syntrinsic's ARKG Position: Q3 2024 in Review

Syntrinsic held its ARK Genomic Revolution ETF (ARKG) position steady in Q3 2024 at 107 shares worth $2.74K. The position accounts for ﹤0.01% of the portfolio, ranked #71.

Syntrinsic first reported a position in ARKG in Q3 2023 and has held it in 5 quarters since. The position peaked at $3.51K in Q4 2023. 239 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

  • Syntrinsic held 107 shares of ARK Genomic Revolution ETF worth $2.74K as of Q3 2024.
  • Syntrinsic left its ARK Genomic Revolution ETF share count unchanged in Q3 2024.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Syntrinsic's portfolio in Q3 2024, its #71 holding.
  • Syntrinsic first reported a position in ARK Genomic Revolution ETF in Q3 2023 and has held it in 5 quarters since.
  • Syntrinsic's ARK Genomic Revolution ETF position peaked at $3.51K in Q4 2023.
  • 239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Syntrinsic's 13F filing for Q3 2024, filed 8 Oct 2024.